$55.3 Million is the total value of Opus Point Partners Management, LLC's 55 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -4,806 | -100.0% | -0.36% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -6,116 | -100.0% | -0.51% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -3,570 | -100.0% | -0.55% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -48,485 | -100.0% | -0.60% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -36,731 | -100.0% | -0.68% | – |
| PCRX | Exit | PACIRA BIOSCIENCES | $0 | – | -11,250 | -100.0% | -0.72% | – |
| INSM | Exit | INSMED INC | $0 | – | -26,936 | -100.0% | -1.02% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -5,840 | -100.0% | -1.10% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -5,353 | -100.0% | -1.20% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -62,575 | -100.0% | -1.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.